CACNA1G and non-small cell lung carcinoma: Here we demonstrate Cav3.1 overexpression is associated with larger tumors, SCC histology, later stage disease at diagnosis and lower OS in patients with NSCLC, and is a potential biomarker for poorer patient outcomes.